Kevin M. Lopez

Kevin M. Lopez

Auto-generated profile, based on publicly available information

Kevin M. Lopez

Neurodegenerative Disease Center, Scintillon Institute, San Diego, CA 92121, USA

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 December 2020 in Science
Verified
Journal Article
Closed access
PDF file
TNTomohiro Nakamura
Tomohiro Nakamura
COChang-Ki Oh
Chang-Ki Oh
LLLujian Liao
Lujian Liao
XZXu Zhang
Xu Zhang
KLKevin M. Lopez
Kevin M. Lopez
Stuart LiptonStuart Lipton
Stuart Lipton
A cascade of NO in Alzheimer's disease: One of the ill effects of the amyloid-β peptide that accumulates in Alzheimer's disease (AD) is the promotion of the production of nitric oxide (NO) and consequent nitrosylation of thiols in proteins such as dynamin-related protein 1 (Drp1), which can lead to loss of neuronal synapses. Nakamura et al. found that this S-nitrosylation occurs in an unusual way. They detected a series of transnitrosylation events in which an NO group is passed between at least three proteins. The deubiquinating enzyme Uch-L1 was S-nitrosylated in brains from human AD patients or in mouse models of AD. Uch-L1 could lead to S-nitrosylation of Drp1 after transferring the NO group to another enzyme, Cdk5 (cyclin-dependent kinase 5). The results implicate a mechanism in which unrelated enzymes might aberrantly function together to disrupt brain function. Science , this issue p. eaaw0843